HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Moretti Selected Research

Biomarkers (Surrogate Marker)

5/2010The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Moretti Research Topics

Disease

15Neoplasms (Cancer)
02/2021 - 08/2007
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2004
9Lung Neoplasms (Lung Cancer)
10/2011 - 05/2008
4Prostatic Neoplasms (Prostate Cancer)
07/2011 - 04/2010
3Rectal Neoplasms (Rectal Cancer)
04/2021 - 07/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2021 - 01/2020
2Adenocarcinoma
02/2021 - 01/2021
2Polyploidy
07/2011 - 04/2011
1Fever (Fevers)
02/2021
1Pancreatitis
02/2021
1Rare Diseases (Rare Disease)
12/2018
1Thymoma (Thymic Carcinoma)
12/2018
1Lung Injury
10/2011
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2010
1Extranodal Extension
11/2009
1Margins of Excision
11/2009
1Disease Progression
03/2009

Drug/Important Bio-Agent (IBA)

4Caspase 3 (Caspase-3)IBA
10/2011 - 05/2008
2Paclitaxel (Taxol)FDA LinkGeneric
10/2011 - 03/2009
2AndrogensIBA
07/2011 - 04/2011
2von Willebrand FactorIBA
07/2011 - 05/2008
2Sirolimus (Rapamycin)FDA Link
08/2010 - 10/2009
1regorafenibIBA
04/2021
1NivolumabIBA
04/2021
1AnthracyclinesIBA
12/2018
1Cisplatin (Platino)FDA LinkGeneric
12/2018
1Etoposide (VP 16)FDA LinkGeneric
12/2018
1PlatinumIBA
12/2018
1LuciferasesIBA
10/2011
1MLN8054IBA
07/2011
1DNA (Deoxyribonucleic Acid)IBA
07/2011
1ParaffinIBA
07/2011
1Aurora Kinase AIBA
07/2011
1NocodazoleIBA
07/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2011
1Aurora Kinase BIBA
04/2011
1TG101209IBA
04/2011
12- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
04/2011
1SurvivinIBA
04/2011
1Hormones (Hormone)IBA
04/2011
1enzastaurinIBA
08/2010
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
08/2010
1matrigelIBA
08/2010
1Protein Kinase CIBA
08/2010
1Prostate-Specific Antigen (Semenogelase)IBA
05/2010
1Biomarkers (Surrogate Marker)IBA
05/2010
1gossypol acetic acidIBA
05/2010
1Biological ProductsIBA
04/2010
1TOR Serine-Threonine KinasesIBA
10/2009
1CaspasesIBA
05/2009
1Celecoxib (Celebrex)FDA Link
03/2009
1Carboplatin (JM8)FDA LinkGeneric
03/2009
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2009
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2009
1Beclin-1IBA
07/2008
1Apoptosis Regulatory ProteinsIBA
05/2008
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2008
1Pharmaceutical PreparationsIBA
08/2007

Therapy/Procedure

19Radiotherapy
01/2022 - 10/2004
7Therapeutics
12/2018 - 08/2007
3Drug Therapy (Chemotherapy)
04/2021 - 11/2009
2Neoadjuvant Therapy
02/2021 - 10/2018
2Adjuvant Chemotherapy
10/2018 - 10/2004
1Proton Therapy
01/2022
1Stents
02/2021
1Immunotherapy
12/2018
1Adjuvant Radiotherapy
12/2018
1Prostatectomy (Retropubic Prostatectomy)
05/2010